GobyMeds vs PlexusDx: Prepaid Bundles vs Flat-Rate GLP-1 Plans

Last reviewed: September 23, 2026 Last updated: September 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

GobyMeds and PlexusDx both offer compounded semaglutide and tirzepatide injections with no separate membership fees, but their pricing models diverge sharply. GobyMeds uses prepaid three-month bundles with dose tiers: semaglutide costs $299, $399, or $499 upfront depending on your dose ceiling (0.2–0.4 mg, up to 1.5 mg, or up to 2.3 mg), and tirzepatide costs $299/month with no prepay option. PlexusDx charges a single flat rate at every dose—$189/month month-to-month for semaglutide, $289/month for tirzepatide—with optional prepaid discounts ($169/month on a three-month plan, $149/month on six months for semaglutide; $269 and $249 respectively for tirzepatide). Over 12 months, GobyMeds' lowest semaglutide tier ($1,196/year) beats every PlexusDx plan if your dose stays at or below 0.4 mg, but that advantage shrinks as dose requirements rise and disappears entirely for tirzepatide, where PlexusDx costs $120–$360 less per year. The trade-off is upfront cash versus month-to-month flexibility and dose-ceiling risk.

At-a-glance comparison

Normalized 12-month costs: prepaid bundles versus flat rates

GobyMeds' prepaid structure and PlexusDx's flat-rate model make month-to-month figures misleading. The tables below show total year-one cost assuming continuous treatment and the effective monthly average (our calculation in both cases).

Semaglutide injection, 12-month cost comparison

Like-for-like analysis: Comparing GobyMeds' prepaid three-month bundles to PlexusDx's three-month plan (the closest structural match), GobyMeds' low tier ($1,196/year) saves $832 versus PlexusDx ($2,028/year)—if your maintenance dose stays at or below 0.4 mg for the full 12 months. At the mid tier (up to 1.5 mg), GobyMeds saves $432. At the high tier (up to 2.3 mg), the gap narrows to $32. PlexusDx's six-month plan ($1,788/year) costs $592 more than GobyMeds' low tier but $208 less than the high tier, and it carries no dose ceiling—a material advantage if your provider titrates above 2.3 mg or if dose requirements fluctuate.

Tirzepatide injection, 12-month cost comparison

Like-for-like analysis: GobyMeds offers only a month-to-month tirzepatide option at $299. PlexusDx's month-to-month rate ($289) saves $120/year; the three-month plan saves $360; the six-month plan saves $600. GobyMeds holds no tirzepatide pricing advantage at any commitment level, and its lack of a prepaid tirzepatide bundle means it cannot compete on upfront discount the way it does with semaglutide.

Decision factors beyond the annual total

Upfront cash requirement and commitment risk

GobyMeds' semaglutide bundles require $299–$499 upfront every 90 days. If you pause or switch providers mid-cycle, you've prepaid for doses you won't receive, and no refund policy is documented in the captured evidence. PlexusDx's month-to-month and multi-month plans bill monthly; multi-month plans carry commitment periods, but you're never more than 30 days ahead on payment. For patients testing tolerance or unsure about long-term adherence, monthly billing reduces cash-flow exposure.

Dose-ceiling risk with tiered pricing

GobyMeds' semaglutide tiers cap your dose at 0.4 mg (low), 1.5 mg (mid), or 2.3 mg (high). If your provider prescribes 1.7 mg and you're on the low tier, you'll need to move to the mid tier mid-cycle—potentially requiring a new $399 payment before your current quarter ends. The evidence does not document how mid-cycle tier changes are billed. PlexusDx charges the same rate whether you're on 0.25 mg or 2.4 mg, eliminating surprise step-ups and simplifying budgeting when dose is uncertain.

Tirzepatide pricing structure

GobyMeds offers tirzepatide at $299/month with no prepaid option and no dose tiers. PlexusDx undercuts that rate at every plan length ($289 month-to-month, $269 on three months, $249 on six months) and applies the same no-dose-tier policy. If you're pursuing tirzepatide, GobyMeds holds no structural or price advantage.

Competitive context: where both providers sit in the low-cost field

Checkout-verified data (captured July 2026, plexusdx.com) shows compounded semaglutide pricing across seven additional telehealth providers: Eden ($198/month including $99 membership), Embody ($299), Found ($289 month-to-month cash pay), Henry Meds ($297), Peak Wellness ($249), and TrimRx ($299 ongoing rate). GobyMeds' low-tier semaglutide rate ($99.67/month equivalent, prepaid) undercuts every option in that cohort if dose requirements permit the low tier. PlexusDx's $189 month-to-month rate is competitive but not the floor; its $149 six-month rate sits below all verified competitors except GobyMeds' low and mid tiers. On tirzepatide, PlexusDx's $289 month-to-month matches Found's rate and beats Embody ($349) and TrimRx ($399), while GobyMeds' $299 falls in the middle of the pack.

Choose GobyMeds if…

• You're confident your semaglutide maintenance dose will stay at or below 0.4 mg for at least 12 months, you have $299 cash available every quarter, and the $832/year savings versus PlexusDx's three-month plan justifies the prepayment and dose-ceiling constraints.
• You expect to titrate into the 0.6–1.5 mg range and can commit to the mid tier ($399 every three months); you'll still save $432/year versus PlexusDx's three-month plan, though the gap narrows if your dose climbs above 1.5 mg.
• You value overnight shipping (included in GobyMeds' bundles) as a service differentiator and are comfortable with the three-month billing cycle.

Choose PlexusDx if…

• You want month-to-month flexibility with no upfront cash requirement and no risk of mid-cycle tier changes—semaglutide costs $189/month regardless of whether your provider prescribes 0.25 mg or 2.4 mg.
• You're pursuing tirzepatide, where PlexusDx costs $10–$50 less per month than GobyMeds at every plan length and offers the same any-dose pricing.
• You prefer a six-month commitment in exchange for a lower per-month rate ($149 semaglutide, $249 tirzepatide) that sits below GobyMeds' mid and high semaglutide tiers and all tirzepatide options.
• You value transparent, dose-independent pricing that simplifies annual budgeting and eliminates the need to predict maintenance dose before committing to a tier.

Methodology and freshness

GobyMeds pricing was captured September 4, 2026, from the provider's publicly accessible pricing page (gobymeds.com/getting-started/pricing) and cross-verified against intake flow screenshots. PlexusDx pricing was captured September 23, 2026, from product pages and the weight-management protocols collection. All 12-month cost projections are our calculation, derived by multiplying the documented per-period rate by the number of periods in one year. GobyMeds' per-month equivalents for prepaid bundles are also our calculation (upfront cost ÷ 3 months). Competitive context pricing (Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx) was checkout-verified July 17–23, 2026, and is included for reference only; readers should confirm current rates at each provider before deciding. No insurance, rebate, or transfer-credit scenarios are modeled. We do not predict individual dose requirements, eligibility, or side-effect outcomes.

Frequently Asked Questions

Does GobyMeds charge less than PlexusDx for semaglutide?

It depends on your dose and plan choice. GobyMeds' low tier ($1,196/year, dose capped at 0.4 mg) costs $832 less than PlexusDx's three-month plan and $592 less than the six-month plan. At the high tier (up to 2.3 mg), GobyMeds costs $1,996/year—$208 more than PlexusDx's six-month plan and only $32 less than the three-month plan. PlexusDx has no dose ceiling, so if you titrate above 2.3 mg, the price stays $149–$189/month.

What happens if my dose outgrows my GobyMeds tier mid-cycle?

The captured evidence does not document GobyMeds' mid-cycle tier-change policy. You should ask the provider directly whether moving from the low tier to the mid tier requires immediate payment of the $100 tier difference or a new $399 bundle, and whether unused doses in your current tier are credited or forfeited. PlexusDx avoids this scenario entirely by charging the same rate at every dose.

Why doesn't GobyMeds offer a prepaid tirzepatide bundle?

GobyMeds' published pricing (captured September 4, 2026) lists only a $299/month tirzepatide option with no three-month prepaid bundle. The reason is not explained in the evidence. As a result, GobyMeds costs $10–$50 more per month than PlexusDx's tirzepatide plans at every commitment level, and the dose-tiered discount structure that makes GobyMeds competitive on semaglutide does not apply to tirzepatide.

Do both providers include syringes, needles, and alcohol swabs?

Yes. GobyMeds states that supplies and overnight shipping are included in the bundle price. PlexusDx includes supplies in the monthly medication cost and ships via standard carrier; expedited shipping options are available but not documented in the pricing capture. Neither provider charges a separate supply fee or membership fee.

Can I switch from GobyMeds to PlexusDx mid-treatment without restarting titration?

Transferring between telehealth GLP-1 providers typically requires a new intake and provider review. Whether the new provider continues your current dose or restarts titration depends on the individual clinician's judgment, your tolerance history, and the transferring provider's protocol. Neither GobyMeds nor PlexusDx guarantees dose continuity for transfer patients. If you're mid-cycle on a GobyMeds prepaid bundle, confirm whether any portion of the prepayment is refundable before switching.

Sources

• PlexusDx weight-management protocols and product pages (plexusdx.com), accessed September 23, 2026
• GobyMeds pricing page (gobymeds.com/getting-started/pricing), accessed September 4, 2026
• PlexusDx competitive pricing research (plexusdx.com, checkout-verified data for Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx), accessed July 17–23, 2026
• Trustpilot profile for PlexusDx (trustpilot.com/review/plexusdx.com), verified September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.